GSTZ1‐1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone

Authors:

Abstract
The IGF1R signaling is important in the malignant progression of cancer. However, overexpression of IGF1R has not been properly assessed in HCC. Here, we revealed that GSTZ1‐1, the enzyme in phenylalanine/tyrosine catabolism, is downregulated in HCC, and its expression was negatively correlated with IGF1R. Mechanistically, GSTZ1‐1 deficiency led to succinylacetone accumulation, alkylation modification of KEAP1, and NRF2 activation, thus promoting IGF1R transcription by recruiting SP1 to its promoter. Moreover, inhibition of IGF1R or NRF2 significantly inhibited tumor‐promoting effects of GSTZ1 knockout in vivo. These findings establish succinylacetone as an oncometabolite, and GSTZ1‐1 as an important tumor suppressor by inhibiting NRF2/IGF1R axis in HCC. Targeting NRF2 or IGF1R may be a promising treatment approach for this subset HCC.
Funding Information
  • National Natural Science Foundation of China (81872270)
  • National Natural Science Foundation of China (81572683)
  • National Natural Science Foundation of China (81661148057)
  • National Natural Science Foundation of China (81602417)
  • Ministry of Science and Technology of the People's Republic of China (2017ZX10202203‐004)
  • Natural Science Foundation of Chongqing Municipality (cstc2018jcyjAX0254)
  • Program for Innovation Team of Higher Education in Chongqing (CXTDX201601015)
  • Leading Talent Program of CQ CSTC (CSTCCXLJRC201719)
  • Scientific Research Innovation Project for Postgraduate in Chongqing (CYB17119)
  • Talent Development Program of CQMU for Postgraduate (BJRC201704)

This publication has 44 references indexed in Scilit: